The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations
The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations: Double Blinded Randomized Placebo-Controlled Trial
Sponsor: Wael Elbanna Clinic
This NA trial investigates Laparoscopic Myomectomy and is currently actively recruiting participants. Wael Elbanna Clinic leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Nov 2023 — Jul 2024 [monthly]
Recruiting NA
-
Jun 2022 — Nov 2023 [monthly]
Recruiting NA
-
Mar 2022 — Jun 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Jan 2022 — Mar 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Wael Elbanna Clinic
For direct contact, visit the study record on ClinicalTrials.gov .